Thursday November 26 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Neurofibromatosis 2

Download PDF containing detailed information.PDF Version

Image Results

Loading...

Recent Publications on Neurofibromatosis 2:

Pubmed Logo
Foramen magnum meningiomas: experiences in 114 patients at a single institute over 15 years.
BACKGROUND: Although there has been great development in the anatomical...
18th November, 2009
Department Neurosurgery, Beijing Tiantan Hospital, Capital Medical Surg Neurol. 2009 Oct;72(4):376-82; discussion 382. Epub 2009 Jul 15.
DOI Direct Link
Concordance of bilateral vestibular schwannoma growth and hearing changes in neurofibromatosis 2: neurofibromatosis 2 natural history consortium.
OBJECTIVE: To examine the relationship between the amount of change in...
17th November, 2009
House Ear Institute, Los Angeles, CA 90057, USA. Otol Neurotol. 2009 Sep;30(6):835-41.
DOI Direct Link
Neurofibromatosis 2 [Bilateral acoustic neurofibromatosis, central neurofibromatosis, NF2, neurofibromatosis type II].
Neurofibromatosis 2 is a dominantly inherited tumor predisposition...
17th November, 2009
Medical Genetics Research Group, Regional Genetics Service and National Genet Med. 2009 Sep;11(9):599-610.
DOI Direct Link
Gastric schwannoma with adjacent external progression harbored aberrant NF2 gene.
Gastric schwannomas are rare benign mesenchymal tumors. We describe a...
13th November, 2009
Department of Gastroenterology, Nagoya City University Graduate School of Dig Endosc. 2009 Jul;21(3):192-5.
DOI Direct Link
The neurofibromatoses. Part 2: NF2 and schwannomatosis.
The neurofibromatoses, including neurofibromatosis 1 (NF1),...
10th November, 2009
Department of Neurology, University of Washington, Seattle, WA, USA. Rev Neurol Dis. 2009 Summer;6(3):E81-6.

View more research publications.

Press Releases About Neurofibromatosis 2:

BioPortfolio Logo
NexGenix Pharmaceuticals Awarded Phase I Grant from the National Institute of Neurological Disorders and Stroke (NINDS) Small Business Innovation Research Program (SBIR) for the Development of Novel Small Molecule Hsp90 Therapeutics to Treat Glioma 22nd October, 2009 NexGenix Pharmaceuticals Holdings, Inc.
NEW YORK, Oct. 22 /PRNewswire/ -- NexGenix Pharmaceuticals Holdings, Inc. a privately-held biotechnology company with a portfolio of novel targeted therapies for oncology and neurodegenerative
PTC Therapeutics Receives $2.6 Million in Government Grants 15th June, 2009 PTC Therapeutics, Inc.
- Funding supports continued focus on rare disorders - SOUTH PLAINFIELD, N.J., June 15 /PRNewswire/ -- PTC Therapeutics, Inc. (PTC) today announced the receipt of two government grants to support

BioNews Results for Neurofibromatosis 2:

RSS Logo
BioPortfolio Logo
Mutation linked to pediatric brain tumor may pave way for targeted treatment
Washington University in St. Louis:  Oct 29 2009 10:24PM Matching: neurofibromatosis 2
Hearing Improvement after Bevacizumab for Neurofibromatosis Type 2
New England Journal of Medicine:  Oct 28 2009 10:27PM Matching: neurofibromatosis 2

Neurofibromatosis 2 Patents:

USPTO Logo
US Patent No.Title
7026447 53 human secreted proteins
7189690 Albumin fusion proteins
7196164 Secreted protein HHTLF25
7205139 Tissue plasminogen activator-like protease
7208274 Rapid analysis of variations in a genome

View more patents.

BioPortfolio Ltd. offers e-mail and postal lists for Neurofibromatosis 2 scientists - we have details of around 108 individuals working on Neurofibromatosis 2 .


This page has been viewed 412 times
Recent Search Terms used to find this page: PTC299, wiki | neurofibromatosis 2 2009 | neurofibromatosis 2 | neurofibroma and portland oregon | progesterone receptors neurofibromatosis 2 | liquids in Neurofibromatosis | Neurofibromatosis 2 | .
Browse BioPortfolio's InDepth service - alphabetically: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z or by Most Publications, recently searched for, or most viewed.

Search for Neurofibromatosis 2 across BioPortfolio, or for Neurofibromatosis 2 Research Reports
Wikipedia excerpt, where present, licenced under the GNU Free Documentation License. Resources from the NCBI applied. Selected MeSH subject headings created and maintained by the US NLM are used in conjunction with additional keywords. 2006-2008 MeSH. Thumbshots from Thumbshots.org

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.